Wednesday, November 25, 2009, 5:28am EST - Canadian Markets open in 4 hours and 2 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Mylan, Inc. (MYL)

 On Nov 24: 18.30 USD   0.00 (0.00%)  
MORE ON MYL
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Mylan Inc. (NasdaqNM:MYL) Delayed quote dataEdit
Last Trade: 18.30 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 18.30
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 19.15
Day's Range: N/A - N/A
52wk Range: 8.62 - 18.45
Volume: 0
Avg Vol (3m): 7,493,290
Market Cap: 5.59B
P/E (ttm): 112.27
EPS (ttm): 0.16
Div & Yield: N/A (N/A%)
Mylan, Inc. (MYL)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add MYL to Portfolio   Download Data

HEADLINES
• Technical Take: 5 Trending Stocks to Watch
at Seeking Alpha (Tue 1:28pm)
• Your First Move For Monday November 23rd
at CNBC (Fri, Nov 20)
• Pfizer's Generic Growth, With a Side of Sashimi
at Motley Fool (Thu, Nov 19)
• Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
PRNewswire (Wed, Nov 18)
• Markets dip slightly by noon Wednesday
at bizjournals.com (Wed, Nov 18)
• 9 Stock Picks for a 'Multi-Year Bull Market': Chief Investor
at CNBC (Tue, Nov 17)
• We're in a Multi-Year Bull Market: Stock Picker
at CNBC (Tue, Nov 17)
• Buy this Consistent Grower: 1 Minute Trade
TheStreet.com TV (Mon, Nov 16)
• Another Win for Mylan
Zacks.com (Fri, Nov 13)
• [video] Buy this Consistent Grower: 1 Minute Trade
at TheStreet.com (Fri, Nov 13)
• The Life-and-Death Situation That Isn't
at Motley Fool (Thu, Nov 12)
• Mylan's Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier
PRNewswire (Thu, Nov 12)
• UPDATE - Ratiopharm gets at least 10 bids -sources
at Reuters (Wed, Nov 11)
More Headlines for MYL...
ANALYST
EPS Est (next year) (Dec-09) : 1.26
EPS Est (in 2 years) (Dec-10) : 1.52
Avg Rec (current)*: 2.2
PEG Ratio: 0.67
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Mylan Inc. and its subsidiaries engage in the development, manufacture, marketing, licensing, and distribution of generic, brand, and branded generic pharmaceutical products and active pharmaceutical ingredients (APIs).

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices